Roche Holding said its weight-loss drug candidate achieved positive results in an early-stage trial, giving the company a boost in its bid to catch up to Novo Nordisk and Eli Lilly in a class of medicines that has shaken up everything from pharma to snack companies.
Trending
- ‘Belgisch H&M distributiecentrum geëvacueerd vanwege gijzeling’
- Tribeca Slams Palestinian “Dog Rape” Joke By ‘The Wedding Entertainer’ Star
- German town prints its own cash to cut CO2 emissions
- One dead, five wounded after shootings in Israel
- NATO drills: France to test AI battlefield tech as alternative to US system
- Iran Court Upholds Prison Sentence, Travel Ban for Jafar Panahi
- Mindy Kaling Talks ‘NSFW’ Series, Her Publishing Imprint, More
- Italy's ITA Airways weighs lawsuit over Pratt & Whitney engine faults
